From innovative therapies to global care strategies, HIV experts at CROI 2026 share the breakthroughs and lessons they hope ...
July 27, 2012 (Washington, DC) — Despite great reductions in opportunistic infections (OIs) since the advent of highly active antiretroviral therapy (HAART) for AIDS, they are still common, and ...
Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...
The presentations can be found on the Posters & Presentations section of the Aligos website ( www.aligos.com) after the live event.
One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after ...
Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...
Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...
Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results